SUMMARY Ninety-three consecutive patients with adult chlamydial ophthalmia were treated with four different regimens of oral doxycycline. In patients treated with a single dose of 5 mg/kg of body weight (300 mg) of doxycycline the severity of clinical signs was reduced, and in half of the patients shedding of the infective agent was stopped. Treatment with a weekly dose of 300 mg of doxycycline for three weeks or a daily dose of 1*5 mg/kg of body weight (100 mg) for one week produced a clinical and microbiological cure in 100% of patients. However, in some of these patients mild to moderate papillary responses were present up to six months from completion of the treatment. The best results were obtained with a daily dose of 100 mg for two weeks, which produced rapid clinical and microbiological cure in all patients.
Adult chlamydial ophthalmia (ACO) or paratrachoma includes inclusion conjunctivitis, TRIC-agent punctate keratoconjunctivitis, and trachoma of sexually transmitted origin.' ACO is generally associated with a concurrent, but mainly asymptomatic, chlamydial genital infection in the patient and/or in the patient's consort(s).23 It is estimated that in the developed countries approximately 1% of the patients with a chlamydial genital infection may develop ACO (unpublished data). However, the prevalence of ACO is increasing because of the rising prevalence of chlamydial genital infections. 4 ACO has been shown to respond well to topical treatment with tetracycline or rifampicin eye ointment when used for a minimum period of six weeks.5 6 However, the major setback in this method of therapy is the patient's poor compliance owing to difficulty with correct application of ointment and the long course of treatment. In addition the concurrent genital infection remains untreated, which may cause reinfection of the eye or other severe complications such as endometritis, pelvic inflammatory disease in women, and infertility in men and women. Further follow-up. Further follow-up showed clinical and microbiological cure in those patients who did not attend regularly during the first three months of the study and were not included in the Tables 1 and 2 .
Adverse reactions. Two of the 22 patients on dose kly doses dose for 1 week Jose for 2 weeks 
Discussion
This open treatment trial was designed to find the optimal regimen of treatment with doxycycline for patients with ACO. The results showed that a single dose of 300 mg doxycycline reduces the severity of clinical signs and stops the shedding of C. trachomatis in about half of the patients. Treatments with a weekly dose for three weeks or a daily dose for one week were equally effective in producing clinical and microbiological cure in all the patients. However, some of these patients showed persistent papillary responses up to six months after completion of treatment, which resolved with no further treatment. The best result, however, was obtained with a daily dose of 100 mg for two weeks, when a rapid resolution of clinical signs was achieved. This finding is consistent with our previous study of treatment of trachoma with doxycycline in a village in Iran. ' The advantages of therapy with doxycycline over other tetracyclines are that it requires minimal daily dose schedules, which greatly enhance patient compliance; it is better absorbed from the gut; and absorption is not affected by diet.
In this study we did not investigate the patients for the presence of chlamydial genital infections before the start oftreatment. Three months after starting it 56 patients who had been treated with weekly or daily doses of doxycycline attended our Genito-Urinary Medicine Clinic. C. trachomatis was not isolated from specimens taken from the genital tract of any of these patients. In previous studies it had been shown that in untreated women and men with ACO 90% and 48% respectively had concomitant microbiologically proved genital chlamydial infections. The failure to isolate C. trachomatis from the genital tract of treated patients in this study suggests that oral doxycycline therapy can simultaneously cure both ocular and genital chlamydial infections.
The results of this study indicate that one weekly dose of doxycycline for three weeks, or a daily dose for one week, or a daily dose for two weeks are effective in the treatment of ACO and its associated genital infections. However, treatment with a daily dose of doxycycline for two weeks produced a faster clinical recovery than the other two regimens.
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